Spain Dialysis Market

1      INTRODUCTION

           1.1      REPORT DESCRIPTION

           1.2      RESEARCH METHODOLOGY

                         1.2.1      SECONDARY RESEARCH

                         1.2.2      DATA ANALYSIS FRAMEWORK

                         1.2.3      MARKET SIZE ESTIMATION

                         1.2.4      FORECASTING

                         1.2.5      PRIMARY RESEARCH AND DATA VALIDATION

2      SPAIN DIALYSIS MARKET – EXECUTIVE SUMMARY

           2.1.      MARKET SNAPSHOT, 2023 - 2030, MILLION USD

3      PORTER’S FIVE FORCE MODEL ANALYSIS

           3.1      BARGAINING POWER OF SUPPLIERS

           3.2      BARGAINING POWER OF BUYERS

           3.3      DEGREE OF COMPETITION

           3.4      THREAT OF SUBSTITUTE

           3.5      THREAT OF NEW ENTRANTS

4      MARKET SHARE ANALYSIS

           4.1      MARKET SHARE ANALYSIS OF TOP PROVIDERS, 2023

5      MARKET DYNAMICS

           5.1      GROWTH DRIVERS

                         5.1.1      DRIVER 1

                         5.1.2      DRIVER 2

                         5.1.3      DRIVER 3

                         5.1.4      DRIVER 4

           5.2      CHALLENGES

                         5.2.1      CHALLENGE 1

                         5.2.2      CHALLENGE 2

                         5.2.3      CHALLENGE 3

                         5.2.4      CHALLENGE 4

           5.3      OPPORTUNITIES

                         5.3.1      OPPORTUNITY 1

                         5.3.2      OPPORTUNITY 2

6       SPAIN DIALYSIS MARKET BY DIALYSIS TYPE

           6.1      OVERVIEW

           6.2      HEMO DIALYSIS MARKET

           6.3      PERITONEAL DIALYSIS MARKET

7       SPAIN DIALYSIS MARKET BY PRODUCTS AND SERVICES

           7.1      OVERVIEW

           7.2      EQUIPMENT MARKET

           7.3      CONSUMABLES MARKET

           7.4      DRUGS MARKET

           7.5      SERVICES MARKET

8       SPAIN DIALYSIS MARKET BY END USER

           8.1      OVERVIEW

           8.2      IN-CENTER DIALYSIS MARKET

           8.3      HOME DIALYSIS MARKET

9     COMPANY PROFILES

           9.1     BAXTER INTERNATIONAL INC.

                         9.1.1     COMPANY OVERVIEW

                         9.1.2     COMPANY SNAPSHOT

                         9.1.3     OPERATING BUSINESS SEGMENTS

                         9.1.4     PRODUCT PORTFOLIO

                         9.1.5     BUSINESS PERFORMANCE

                         9.1.6     BUSINESS SEGMENTS

                         9.1.7     GEOGRAPHIC SEGMENTS

                         9.1.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.1.9     PRIMARY MARKET COMPETITORS

           9.2     DAVITA INC.

                         9.2.1     COMPANY OVERVIEW

                         9.2.2     COMPANY SNAPSHOT

                         9.2.3     OPERATING BUSINESS SEGMENTS

                         9.2.4     PRODUCT PORTFOLIO

                         9.2.5     BUSINESS PERFORMANCE

                         9.2.6     BUSINESS SEGMENTS

                         9.2.7     GEOGRAPHIC SEGMENTS

                         9.2.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.2.9     PRIMARY MARKET COMPETITORS

           9.3     NIKKISO CO. LTD.

                         9.3.1     COMPANY OVERVIEW

                         9.3.2     COMPANY SNAPSHOT

                         9.3.3     OPERATING BUSINESS SEGMENTS

                         9.3.4     PRODUCT PORTFOLIO

                         9.3.5     BUSINESS PERFORMANCE

                         9.3.6     BUSINESS SEGMENTS

                         9.3.7     GEOGRAPHIC SEGMENTS

                         9.3.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.3.9     PRIMARY MARKET COMPETITORS

           9.4     NXSTAGE MEDICAL, INC.

                         9.4.1     COMPANY OVERVIEW

                         9.4.2     COMPANY SNAPSHOT

                         9.4.3     OPERATING BUSINESS SEGMENTS

                         9.4.4     PRODUCT PORTFOLIO

                         9.4.5     BUSINESS PERFORMANCE

                         9.4.6     BUSINESS SEGMENTS

                         9.4.7     GEOGRAPHIC SEGMENTS

                         9.4.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.4.9     PRIMARY MARKET COMPETITORS

           9.5     ASAHI KASEI CORPORATION

                         9.5.1     COMPANY OVERVIEW

                         9.5.2     COMPANY SNAPSHOT

                         9.5.3     OPERATING BUSINESS SEGMENTS

                         9.5.4     PRODUCT PORTFOLIO

                         9.5.5     BUSINESS PERFORMANCE

                         9.5.6     BUSINESS SEGMENTS

                         9.5.7     GEOGRAPHIC SEGMENTS

                         9.5.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.5.9     PRIMARY MARKET COMPETITORS

           9.6     MEDICATORS, INC.

                         9.6.1     COMPANY OVERVIEW

                         9.6.2     COMPANY SNAPSHOT

                         9.6.3     OPERATING BUSINESS SEGMENTS

                         9.6.4     PRODUCT PORTFOLIO

                         9.6.5     BUSINESS PERFORMANCE

                         9.6.6     BUSINESS SEGMENTS

                         9.6.7     GEOGRAPHIC SEGMENTS

                         9.6.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.6.9     PRIMARY MARKET COMPETITORS

           9.7     FRESENIUS MEDICAL CARE AG AND CO. KGAA

                         9.7.1     COMPANY OVERVIEW

                         9.7.2     COMPANY SNAPSHOT

                         9.7.3     OPERATING BUSINESS SEGMENTS

                         9.7.4     PRODUCT PORTFOLIO

                         9.7.5     BUSINESS PERFORMANCE

                         9.7.6     BUSINESS SEGMENTS

                         9.7.7     GEOGRAPHIC SEGMENTS

                         9.7.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.7.9     PRIMARY MARKET COMPETITORS

           9.8     NIPRO CORPORATION

                         9.8.1     COMPANY OVERVIEW

                         9.8.2     COMPANY SNAPSHOT

                         9.8.3     OPERATING BUSINESS SEGMENTS

                         9.8.4     PRODUCT PORTFOLIO

                         9.8.5     BUSINESS PERFORMANCE

                         9.8.6     BUSINESS SEGMENTS

                         9.8.7     GEOGRAPHIC SEGMENTS

                         9.8.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.8.9     PRIMARY MARKET COMPETITORS

           9.9     B. BRAUN AVITUM AG

                         9.9.1     COMPANY OVERVIEW

                         9.9.2     COMPANY SNAPSHOT

                         9.9.3     OPERATING BUSINESS SEGMENTS

                         9.9.4     PRODUCT PORTFOLIO

                         9.9.5     BUSINESS PERFORMANCE

                         9.9.6     BUSINESS SEGMENTS

                         9.9.7     GEOGRAPHIC SEGMENTS

                         9.9.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.9.9     PRIMARY MARKET COMPETITORS

           9.10     DIAVERUM DEUTSCHLAND GMBH

                         9.10.1     COMPANY OVERVIEW

                         9.10.2     COMPANY SNAPSHOT

                         9.10.3     OPERATING BUSINESS SEGMENTS

                         9.10.4     PRODUCT PORTFOLIO

                         9.10.5     BUSINESS PERFORMANCE

                         9.10.6     BUSINESS SEGMENTS

                         9.10.7     GEOGRAPHIC SEGMENTS

                         9.10.8     KEY STRATEGIC MOVES AND DEVELOPMENT

                         9.10.9     PRIMARY MARKET COMPETITORS

LIST OF TABLES

TABLE 1. SPAIN DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

TABLE 2. HEMO DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 3. PERITONEAL DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 4. SPAIN DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

TABLE 5. EQUIPMENT, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 6. CONSUMABLES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 7. DRUGS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 8. SERVICES, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 9. SPAIN DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

TABLE 10. IN-CENTER DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 11. HOME DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

TABLE 12. BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT

TABLE 13. BAXTER INTERNATIONAL INC.: OPERATING BUSINESS SEGMENTS

TABLE 14. BAXTER INTERNATIONAL INC.: PRODUCT PORTFOLIO

TABLE 15. BAXTER INTERNATIONAL INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 16. BAXTER INTERNATIONAL INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 17. BAXTER INTERNATIONAL INC.: KEY STRATERGY

TABLE 18. DAVITA INC.: COMPANY SNAPSHOT

TABLE 19. DAVITA INC.: OPERATING BUSINESS SEGMENTS

TABLE 20. DAVITA INC.: PRODUCT PORTFOLIO

TABLE 21. DAVITA INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 22. DAVITA INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 23. DAVITA INC.: KEY STRATERGY

TABLE 24. NIKKISO CO. LTD.: COMPANY SNAPSHOT

TABLE 25. NIKKISO CO. LTD.: OPERATING BUSINESS SEGMENTS

TABLE 26. NIKKISO CO. LTD.: PRODUCT PORTFOLIO

TABLE 27. NIKKISO CO. LTD.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 28. NIKKISO CO. LTD.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 29. NIKKISO CO. LTD.: KEY STRATERGY

TABLE 30. NXSTAGE MEDICAL, INC.: COMPANY SNAPSHOT

TABLE 31. NXSTAGE MEDICAL, INC.: OPERATING BUSINESS SEGMENTS

TABLE 32. NXSTAGE MEDICAL, INC.: PRODUCT PORTFOLIO

TABLE 33. NXSTAGE MEDICAL, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 34. NXSTAGE MEDICAL, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 35. NXSTAGE MEDICAL, INC.: KEY STRATERGY

TABLE 36. ASAHI KASEI CORPORATION: COMPANY SNAPSHOT

TABLE 37. ASAHI KASEI CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 38. ASAHI KASEI CORPORATION: PRODUCT PORTFOLIO

TABLE 39. ASAHI KASEI CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 40. ASAHI KASEI CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 41. ASAHI KASEI CORPORATION: KEY STRATERGY

TABLE 42. MEDICATORS, INC.: COMPANY SNAPSHOT

TABLE 43. MEDICATORS, INC.: OPERATING BUSINESS SEGMENTS

TABLE 44. MEDICATORS, INC.: PRODUCT PORTFOLIO

TABLE 45. MEDICATORS, INC.: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 46. MEDICATORS, INC.: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 47. MEDICATORS, INC.: KEY STRATERGY

TABLE 48. FRESENIUS MEDICAL CARE AG AND CO. KGAA: COMPANY SNAPSHOT

TABLE 49. FRESENIUS MEDICAL CARE AG AND CO. KGAA: OPERATING BUSINESS SEGMENTS

TABLE 50. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRODUCT PORTFOLIO

TABLE 51. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 52. FRESENIUS MEDICAL CARE AG AND CO. KGAA: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 53. FRESENIUS MEDICAL CARE AG AND CO. KGAA: KEY STRATERGY

TABLE 54. NIPRO CORPORATION: COMPANY SNAPSHOT

TABLE 55. NIPRO CORPORATION: OPERATING BUSINESS SEGMENTS

TABLE 56. NIPRO CORPORATION: PRODUCT PORTFOLIO

TABLE 57. NIPRO CORPORATION: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 58. NIPRO CORPORATION: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 59. NIPRO CORPORATION: KEY STRATERGY

TABLE 60. B. BRAUN AVITUM AG: COMPANY SNAPSHOT

TABLE 61. B. BRAUN AVITUM AG: OPERATING BUSINESS SEGMENTS

TABLE 62. B. BRAUN AVITUM AG: PRODUCT PORTFOLIO

TABLE 63. B. BRAUN AVITUM AG: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 64. B. BRAUN AVITUM AG: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 65. B. BRAUN AVITUM AG: KEY STRATERGY

TABLE 66. DIAVERUM DEUTSCHLAND GMBH: COMPANY SNAPSHOT

TABLE 67. DIAVERUM DEUTSCHLAND GMBH: OPERATING BUSINESS SEGMENTS

TABLE 68. DIAVERUM DEUTSCHLAND GMBH: PRODUCT PORTFOLIO

TABLE 69. DIAVERUM DEUTSCHLAND GMBH: SALES BY BUSINESS SEGMENTS (2021-2023)

TABLE 70. DIAVERUM DEUTSCHLAND GMBH: SALES BY GEOGRAPHIC SEGMENTS (2021-2023)

TABLE 71. DIAVERUM DEUTSCHLAND GMBH: KEY STRATERGY

LIST OF FIGURES

FIGURE 1. BARGAINING POWER OF SUPPLIERS

FIGURE 2. BARGAINING POWER OF BUYERS

FIGURE 3. DEGREE OF COMPETITION

FIGURE 4. THREAT OF SUBSTITUTE

FIGURE 5. THREAT OF NEW ENTRANTS

FIGURE 6. SPAIN DIALYSIS MARKET VALUE, BY DIALYSIS TYPE, 2023-2030, (MILLION USD)

FIGURE 7. HEMO DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 8. PERITONEAL DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 9. SPAIN DIALYSIS MARKET VALUE, BY PRODUCTS AND SERVICES, 2023-2030, (MILLION USD)

FIGURE 10. EQUIPMENT, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 11. CONSUMABLES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 12. DRUGS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 13. SERVICES, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 14. SPAIN DIALYSIS MARKET VALUE, BY END USER, 2023-2030, (MILLION USD)

FIGURE 15. IN-CENTER DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 16. HOME DIALYSIS, MARKET VALUE, 2023-2030, (MILLION USD)

FIGURE 17. BAXTER INTERNATIONAL INC.: NET SALES, (2021-2023)

FIGURE 18. BAXTER INTERNATIONAL INC.: PRIMARY MARKET COMPETITORS

FIGURE 19. DAVITA INC.: NET SALES, (2021-2023)

FIGURE 20. DAVITA INC.: PRIMARY MARKET COMPETITORS

FIGURE 21. NIKKISO CO. LTD.: NET SALES, (2021-2023)

FIGURE 22. NIKKISO CO. LTD.: PRIMARY MARKET COMPETITORS

FIGURE 23. NXSTAGE MEDICAL, INC.: NET SALES, (2021-2023)

FIGURE 24. NXSTAGE MEDICAL, INC.: PRIMARY MARKET COMPETITORS

FIGURE 25. ASAHI KASEI CORPORATION: NET SALES, (2021-2023)

FIGURE 26. ASAHI KASEI CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 27. MEDICATORS, INC.: NET SALES, (2021-2023)

FIGURE 28. MEDICATORS, INC.: PRIMARY MARKET COMPETITORS

FIGURE 29. FRESENIUS MEDICAL CARE AG AND CO. KGAA: NET SALES, (2021-2023)

FIGURE 30. FRESENIUS MEDICAL CARE AG AND CO. KGAA: PRIMARY MARKET COMPETITORS

FIGURE 31. NIPRO CORPORATION: NET SALES, (2021-2023)

FIGURE 32. NIPRO CORPORATION: PRIMARY MARKET COMPETITORS

FIGURE 33. B. BRAUN AVITUM AG: NET SALES, (2021-2023)

FIGURE 34. B. BRAUN AVITUM AG: PRIMARY MARKET COMPETITORS

FIGURE 35. DIAVERUM DEUTSCHLAND GMBH: NET SALES, (2021-2023)

FIGURE 36. DIAVERUM DEUTSCHLAND GMBH: PRIMARY MARKET COMPETITORS

 

At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.

Research Landscape

We navigate the world of research with two primary approaches:

Qualitative Approach

Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.

Quantitative Research

In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.

Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.

Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.

 

Our Specialized Toolbox for Industry-Specific Market Research

We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:

Information Procurement

The stage entails acquiring market data or relevant information through various sources and methodologies.

Market Research Approach

We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.

Porters Five Forces Analysis

We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.

              

SWOT Analysis

We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.

Forecasting

We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.